NYSE:CAH - Cardinal Health Stock Price, Price Target & More

$63.68 +0.11 (+0.17 %)
(As of 04/26/2018 11:31 AM ET)
Previous Close$63.57
Today's Range$63.15 - $64.11
52-Week Range$54.66 - $80.37
Volume569,644 shs
Average Volume2.95 million shs
Market Capitalization$19.63 billion
P/E Ratio11.77
Dividend Yield2.97%
Beta1.07

About Cardinal Health (NYSE:CAH)

Cardinal Health logoCardinal Health, Inc. operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers. This segment also operates nuclear pharmacies and manufacturing facilities that manufacture, prepare, and deliver radiopharmaceuticals, as well as operates direct-to-patient specialty pharmacies; offers logistics, marketing, and other services; and repackages generic pharmaceuticals and over-the-counter healthcare products. The company's Medical segment manufactures and sources medical, surgical, and laboratory products, including cardiovascular and endovascular products; wound care products; surgical drapes, gowns, and apparel; exam and surgical gloves; fluid suction and collection systems; and incontinence, enteral feeding, urology, operating room supply, electrode and needle, and syringe and sharps disposal product lines. It also distributes medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers, as well as to patients in the home; and assembles and sells sterile and non-sterile procedure kits. In addition, it offers supply chain services to healthcare providers; and post-acute care management, and transition services and software to hospitals, other healthcare providers, and payers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

Receive CAH News and Ratings via Email

Sign-up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:CAH
CUSIP14149Y10
Phone614-757-5000

Debt

Debt-to-Equity Ratio1.19%
Current Ratio1.09%
Quick Ratio0.57%

Price-To-Earnings

Trailing P/E Ratio11.77
Forward P/E Ratio11.77
P/E Growth1.43

Sales & Book Value

Annual Sales$129.98 billion
Price / Sales0.15
Cash Flow$7.9007 per share
Price / Cash8.06
Book Value$21.62 per share
Price / Book2.95

Profitability

EPS (Most Recent Fiscal Year)$5.40
Net Income$1.29 billion
Net Margins1.37%
Return on Equity24.81%
Return on Assets4.34%

Miscellaneous

Employees28,000
Outstanding Shares314,710,000

How to Become a New Pot Stock Millionaire

Cardinal Health (NYSE:CAH) Frequently Asked Questions

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health declared a quarterly dividend on Wednesday, February 7th. Investors of record on Monday, April 2nd will be given a dividend of $0.4624 per share on Sunday, April 15th. This represents a $1.85 dividend on an annualized basis and a yield of 2.90%. The ex-dividend date is Thursday, March 29th. View Cardinal Health's Dividend History.

How will Cardinal Health's stock buyback program work?

Cardinal Health announced that its board has initiated a share repurchase plan on Thursday, February 8th 2018, which authorizes the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

How were Cardinal Health's earnings last quarter?

Cardinal Health (NYSE:CAH) posted its quarterly earnings data on Thursday, February, 8th. The company reported $1.31 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.14 by $0.17. The business earned $35.19 billion during the quarter, compared to analysts' expectations of $34.63 billion. Cardinal Health had a return on equity of 24.81% and a net margin of 1.37%. The firm's revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the business earned $1.34 earnings per share. View Cardinal Health's Earnings History.

When is Cardinal Health's next earnings date?

Cardinal Health is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Cardinal Health.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health issued an update on its FY18 earnings guidance on Thursday, February, 8th. The company provided earnings per share guidance of $5.25-$5.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.16.

What price target have analysts set for CAH?

16 brokerages have issued 12 month target prices for Cardinal Health's shares. Their forecasts range from $64.00 to $85.00. On average, they anticipate Cardinal Health's stock price to reach $74.2308 in the next year. View Analyst Ratings for Cardinal Health.

Who are some of Cardinal Health's key competitors?

Who are Cardinal Health's key executives?

Cardinal Health's management team includes the folowing people:
  • Mr. George S. Barrett, Exec. Chairman (Age 63)
  • Mr. Michael C. Kaufmann, CEO & Director (Age 55)
  • Mr. Craig S. Morford, Chief Legal & Compliance Officer (Age 59)
  • Mr. Jon L. Giacomin, Chief Exec. Officer of Medical Segment (Age 53)
  • Mr. Donald M. Casey Jr., Chief Exec. Officer of Medical Segment (Age 58)

Has Cardinal Health been receiving favorable news coverage?

News articles about CAH stock have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Cardinal Health earned a daily sentiment score of 0.11 on Accern's scale. They also gave news headlines about the company an impact score of 47.48 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of Cardinal Health?

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardinal Health's stock price today?

One share of CAH stock can currently be purchased for approximately $63.68.

How big of a company is Cardinal Health?

Cardinal Health has a market capitalization of $19.63 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

How can I contact Cardinal Health?

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]


MarketBeat Community Rating for Cardinal Health (CAH)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  526 (Vote Outperform)
Underperform Votes:  356 (Vote Underperform)
Total Votes:  882
MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe CAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CAH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cardinal Health (NYSE:CAH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for Cardinal Health in the last 12 months. Their average twelve-month price target is $74.2308, suggesting that the stock has a possible upside of 16.57%. The high price target for CAH is $85.00 and the low price target for CAH is $64.00. There are currently 2 sell ratings, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.132.002.132.31
Ratings Breakdown: 2 Sell Rating(s)
10 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
13 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
12 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $74.2308$73.75$73.4545$75.50
Price Target Upside: 16.57% upside5.30% upside0.33% upside13.64% upside

Cardinal Health (NYSE:CAH) Consensus Price Target History

Price Target History for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/24/2018Royal Bank of CanadaSet Price TargetHold$81.00MediumView Rating Details
4/24/2018Leerink SwannUpgradeMarket Perform -> Outperform$75.00LowView Rating Details
4/16/2018BarclaysLower Price TargetEqual Weight -> Equal Weight$74.00 -> $68.00MediumView Rating Details
4/2/2018ArgusUpgradeHold -> Buy$85.00HighView Rating Details
2/27/2018Bank of AmericaInitiated CoverageUnderperform -> Underperform$69.00LowView Rating Details
2/9/2018Jefferies GroupSet Price TargetHold$72.00LowView Rating Details
1/24/2018MizuhoSet Price TargetHold$73.00LowView Rating Details
1/17/2018Robert W. BairdReiterated RatingHold$80.00MediumView Rating Details
1/4/2018Evercore ISIInitiated CoverageIn -> In-Line$67.00MediumView Rating Details
12/4/2017Deutsche BankInitiated CoverageHold$64.00HighView Rating Details
11/20/2017Morgan StanleyDowngradeEqual Weight -> UnderweightN/AView Rating Details
10/12/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
10/10/2017CowenUpgradeBuy$74.00N/AView Rating Details
8/9/2017UBSReiterated RatingNeutral$79.00 -> $76.00MediumView Rating Details
8/3/2017Credit Suisse GroupLower Price TargetOutperform$87.00 -> $81.00MediumView Rating Details
4/28/2017Tigress FinancialInitiated CoverageNeutral -> NeutralLowView Rating Details
4/19/2017William BlairDowngradeOutperform -> Market PerformLowView Rating Details
10/10/2016Cleveland ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/16/2016Goldman SachsDowngradeBuy -> Neutral$90.00 -> $83.00N/AView Rating Details
8/3/2016CitigroupBoost Price TargetNeutral$87.00 -> $93.00N/AView Rating Details
6/20/2016FBR & CoReiterated RatingBuyN/AView Rating Details
6/1/2016Raymond JamesDowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Cardinal Health (NYSE:CAH) Earnings History and Estimates Chart

Earnings by Quarter for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) Earnings Estimates

2018 EPS Consensus Estimate: $5.10
2019 EPS Consensus Estimate: $6.41
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.99$1.18$1.08
Q2 20183$1.10$1.21$1.16
Q3 20183$1.43$1.78$1.55
Q4 20183$1.23$1.48$1.31
Q1 20192$1.40$1.40$1.40
Q2 20192$1.59$1.69$1.64
Q3 20192$1.73$1.78$1.76
Q4 20192$1.58$1.64$1.61

Cardinal Health (NYSE CAH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2018        
2/8/2018Q2 2018$1.14$1.31$34.6276 billion$35.1860 billionViewN/AView Earnings Details
11/6/2017Q1 2018$1.00$1.09$33.4831 billion$32.6410 billionViewN/AView Earnings Details
8/2/2017Q4 2017$1.24$1.31$32.7337 billion$32.9660 billionViewListenView Earnings Details
5/1/2017Q3 2017$1.4580$1.53$32.3016 billion$31.8210 billionViewListenView Earnings Details
2/7/2017Q217$1.23$1.34$33.63 billion$33.10 billionViewListenView Earnings Details
10/31/2016Q117$1.21$1.24$31.12 billion$32.00 billionViewListenView Earnings Details
8/2/2016Q416$1.13$1.14$31.06 billion$31.40 billionViewN/AView Earnings Details
4/28/2016Q316$1.33$1.43$30.54 billion$30.70 billionViewListenView Earnings Details
2/1/2016Q216$1.26$1.30$29.23 billion$31.40 billionViewN/AView Earnings Details
11/2/2015Q116$1.10$1.38$27.19 billion$28.10 billionViewN/AView Earnings Details
7/30/2015Q415$0.99$1.00$26.05 billion$27.50 billionViewListenView Earnings Details
4/30/2015Q3$1.16$1.19$24.3979 billion$25.3750 billionViewN/AView Earnings Details
1/29/2015Q215$1.11$1.20$23.43 billion$25.50 billionViewN/AView Earnings Details
10/30/2014Q115$0.96$1.00$22.43 billion$24.07 billionViewN/AView Earnings Details
8/4/2014Q414$0.81$0.83$21.88 billion$2.90 billionViewN/AView Earnings Details
5/1/2014Q314$1.01$1.01$21.72 million$21.40 millionViewN/AView Earnings Details
1/31/2014Q214$0.84$0.79$20.74 billion$22.20 billionViewN/AView Earnings Details
10/31/2013Q114$0.86$1.10$22.73 billion$24.50 billionViewN/AView Earnings Details
8/1/2013Q4 2013$0.77$0.79$24.56 billion$25.40 billionViewN/AView Earnings Details
5/2/2013Q3 2013$0.95$1.20$24.72 billion$24.60 billionViewN/AView Earnings Details
2/5/2013Q2 2013$0.86$0.93$24.61 million$22.75 millionViewN/AView Earnings Details
10/30/2012Q113$0.79$0.81$26.33 million$25.90 millionViewN/AView Earnings Details
8/2/2012$0.73$0.73ViewN/AView Earnings Details
5/3/2012$0.88$0.94ViewN/AView Earnings Details
2/2/2012$0.77$0.81ViewN/AView Earnings Details
10/27/2011$0.72$0.73ViewN/AView Earnings Details
8/4/2011$0.58$0.59ViewN/AView Earnings Details
4/28/2011$0.69$0.75ViewN/AView Earnings Details
2/3/2011$0.61$0.69ViewN/AView Earnings Details
10/28/2010Q1 2011$0.53$0.64ViewN/AView Earnings Details
8/5/2010Q4 2010$0.49$0.50ViewN/AView Earnings Details
4/29/2010Q3 2010$0.57$0.61ViewN/AView Earnings Details
1/28/2010Q2 2010$0.46$0.57ViewN/AView Earnings Details
11/5/2009Q1 2010$0.43$0.54ViewN/AView Earnings Details
8/18/2009Q4 2009$0.86$0.86ViewN/AView Earnings Details
4/30/2009Q3 2009$0.95$0.97ViewN/AView Earnings Details
2/5/2009Q2 2009$0.89$0.93ViewN/AView Earnings Details
10/29/2008Q1 2009$0.70$0.74ViewN/AView Earnings Details
8/7/2008Q4 2008$0.95$0.97ViewN/AView Earnings Details
5/1/2008Q3 2008$1.00$1.08ViewN/AView Earnings Details
1/29/2008Q2 2008$0.88$0.90ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Cardinal Health (NYSE:CAH) Dividend Information

Cardinal Health pays an annual dividend of $1.85 per share, with a dividend yield of 2.91%. CAH's most recent quarterly dividend payment was Sunday, April 15. The company has grown its dividend for the last 13 consecutive years and is increasing its dividend by an average of 12.20% each year. Cardinal Health pays out 34.26% of its earnings out as a dividend.
Most Recent Dividend:4/15/2018
Annual Dividend:$1.85
Dividend Yield:2.91%
Dividend Growth:12.20% (3 Year Average)
Payout Ratio:34.26% (Trailing 12 Months of Earnings)
34.20% (Based on This Year's Estimates)
30.48% (Based on Next Year's Estimates)
Track Record:13 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/7/2018quarterly$0.46242.95%3/29/20184/2/20184/15/2018
11/8/2017quarterly$0.46243.05%12/29/20171/2/20181/15/2018
8/9/2017quarterly$0.46242.75%9/29/201710/2/201710/15/2017
5/3/2017quarterly$0.46242.54%6/29/20177/3/20177/15/2017
2/2/2017quarterly$0.44892.4%3/30/20174/3/20174/15/2017
11/3/2016quarterly$0.44892.76%12/29/20161/3/20171/15/2017
8/8/2016quarterly$0.44892.14%9/29/201610/3/201610/15/2016
5/4/2016quarterly$0.44892.29%6/29/20167/1/20167/15/2016
2/2/2016quarterly$0.38702%3/30/20164/1/20164/15/2016
11/4/2015quarterly$0.38701.76%12/30/20151/4/20161/15/2016
8/5/2015quarterly$0.38701.83%9/29/201510/1/201510/15/2015
5/6/2015quarterly$0.38701.82%6/29/20157/1/20157/15/2015
2/3/2015quarterly$0.34251.62%3/30/20154/1/20154/15/2015
11/5/2014quarterly$0.34251.72%12/30/20141/2/20151/15/2015
8/6/2014quarterly$0.34251.96%9/29/201410/1/201410/15/2014
5/7/2014quarterly$0.34252.14%6/27/20147/1/20147/15/2014
2/5/2014quarterly$0.30251.83%3/28/20144/1/20144/15/2014
11/6/2013quarterly$0.30251.99%12/30/20131/2/20141/15/2014
8/7/2013quarterly$0.30252.35%9/27/201310/1/201310/15/2013
5/2/2013quarterly$0.30252.61%6/27/20137/1/20137/15/2013
2/6/2013quarterly$0.27502.46%3/27/20134/1/20134/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Cardinal Health (NYSE CAH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 89.98%
Insider Trading History for Cardinal Health (NYSE:CAH)
Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE CAH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Jon L GiacominCEOSell7,995$68.78$549,896.1063,043View SEC Filing  
2/14/2018Patricia MorrisonInsiderSell28,532$66.30$1,891,671.6036,157View SEC Filing  
1/22/2018Michael C KaufmannCEOSell18,586$73.90$1,373,505.40211,849View SEC Filing  
5/12/2017Jon L GiacominCEO of Cardinal Health's pharmaceutical segmentSell23,270$72.87$1,695,684.9055,440View SEC Filing  
2/10/2017George S BarrettChairmanSell217,994$77.23$16,835,676.62682,225View SEC Filing  
11/10/2016George S BarrettChairmanSell217,995$71.29$15,540,863.55682,226View SEC Filing  
8/18/2016Patricia MorrisonInsiderSell43,959$82.50$3,626,617.5099,662View SEC Filing  
8/18/2016Stuart G LawsSVPSell9,703$82.45$800,012.352,718View SEC Filing  
8/16/2016Jon L GiacominCEOSell47,251$82.77$3,910,965.2744,598View SEC Filing  
8/11/2016Craig S MorfordInsiderSell12,697$83.13$1,055,501.6190,811View SEC Filing  
8/10/2016Donald M Jr. CaseyCEOSell59,180$83.59$4,946,856.20164,803View SEC Filing  
8/10/2016George S BarrettChairmanSell250,000$83.63$20,907,500.00510,762View SEC Filing  
8/9/2016George S BarrettCEOSell129,818$83.76$10,873,555.68510,762View SEC Filing  
8/8/2016George S BarrettCEOSell20,428$83.75$1,710,845.00510,762View SEC Filing  
5/20/2016Carole S WatkinsInsiderSell84,617$77.33$6,543,432.61116,202View SEC Filing  
11/6/2015Falk T. StephenEVPSell30,085$87.66$2,637,251.1033,633View SEC Filing  
8/20/2015George S. BarrettCEOSell300,000$83.08$24,924,000.00406,134View SEC Filing  
5/12/2015Falk T StephenEVPSell39,428$86.12$3,395,539.36View SEC Filing  
5/11/2015George S BarrettCEOSell300,000$86.44$25,932,000.00View SEC Filing  
3/4/2015Colleen F ArnoldDirectorSell9,801$87.65$859,057.65View SEC Filing  
3/3/2015Richard C NotebaertDirectorSell9,801$88.20$864,448.20View SEC Filing  
2/20/2015Carole S WatkinsInsiderSell33,847$87.00$2,944,689.00View SEC Filing  
2/10/2015Carole S WatkinsInsiderSell50,770$85.00$4,315,450.00View SEC Filing  
2/10/2015George S BarrettCEOSell300,000$84.87$25,461,000.00View SEC Filing  
11/7/2014Mark R BlakeEVPSell24,668$79.50$1,961,106.00View SEC Filing  
9/5/2014Carole S WatkinsInsiderSell40,794$75.00$3,059,550.00View SEC Filing  
9/4/2014Michael C KaufmannCEOSell50,216$74.95$3,763,689.20View SEC Filing  
8/27/2014Jeffrey William HendersonCFOSell26,567$72.63$1,929,561.21View SEC Filing  
8/18/2014Jeffrey William HendersonCFOSell78,637$72.06$5,666,582.22View SEC Filing  
8/18/2014Mark R BlakeEVPSell4,782$72.15$345,021.30View SEC Filing  
8/18/2014Michael C KaufmannCEOSell6,833$72.06$492,385.98View SEC Filing  
8/8/2014Craig S MorfordInsiderSell43,359$70.03$3,036,430.77View SEC Filing  
8/8/2014Jeffrey William HendersonCFOSell118,093$69.72$8,233,443.96View SEC Filing  
7/24/2014Mark R BlakeEVPSell23,114$73.41$1,696,798.74View SEC Filing  
7/24/2014Stuart G LawsCAOSell21,266$72.50$1,541,785.00View SEC Filing  
7/14/2014Jeffrey William HendersonCFOSell23,632$70.65$1,669,600.80View SEC Filing  
5/19/2014Mark BlakeEVPSell4,703$66.50$312,749.5024,416View SEC Filing  
5/13/2014Mark BlakeEVPSell2,822$66.50$187,663.0029,119View SEC Filing  
5/7/2014Jeffrey William HendersonCFOSell27,031$63.83$1,725,388.73107,096View SEC Filing  
2/11/2014Mark BlakeEVPSell2,330$68.53$159,674.9031,941View SEC Filing  
2/11/2014Michael KaufmannCEOSell388,995$67.46$26,241,602.70115,969View SEC Filing  
2/10/2014George BarrettCEOSell200,000$66.64$13,328,000.00334,102View SEC Filing  
2/5/2014Gregory KennyDirectorSell18,175$65.39$1,188,463.2519,584View SEC Filing  
2/4/2014Carole WatkinsInsiderSell46,666$65.71$3,066,422.8653,544View SEC Filing  
2/4/2014Falk StephenEVPSell17,926$65.56$1,175,228.5624,239View SEC Filing  
2/4/2014Richard NotebaertDirectorSell10,727$65.68$704,549.3633,750View SEC Filing  
11/11/2013George BarrettCEOSell200,000$62.71$12,542,000.00334,102View SEC Filing  
9/11/2013Mark R BlakeEVPSell14,584$51.53$751,513.52View SEC Filing  
8/19/2013Mark BlakeEVPSell4,925$51.27$252,504.7530,641View SEC Filing  
8/16/2013Falk StephenEVPSell10,000$51.50$515,000.0034,239View SEC Filing  
8/15/2013Craig MorfordInsiderSell20,000$51.33$1,026,600.0081,554View SEC Filing  
8/13/2013George BarrettCEOSell75,000$52.09$3,906,750.00325,787View SEC Filing  
8/13/2013Jeffrey William HendersonCFOSell54,590$51.99$2,838,134.10167,390View SEC Filing  
8/8/2013Calvin DardenDirectorSell3,254$51.48$167,515.9218,131View SEC Filing  
8/5/2013Mark BlakeEVPSell29,166$51.53$1,502,923.9832,741View SEC Filing  
7/26/2013Jeffrey William HendersonCFOSell76,781$50.99$3,915,063.19View SEC Filing  
7/18/2013Jeffrey William HendersonCFOSell57,623$49.99$2,880,573.77View SEC Filing  
7/15/2013Jeffrey William HendersonCFOSell14,660$49.99$732,853.40View SEC Filing  
7/11/2013Jeffrey William HendersonCFOSell83,211$48.99$4,076,506.89View SEC Filing  
6/19/2013John F FinnDirectorSell11,070$48.51$537,005.70View SEC Filing  
5/28/2013Jean G SpauldingDirectorSell8,350$47.35$395,372.50View SEC Filing  
5/22/2013Richard C NotebaertDirectorSell3,197$48.10$153,775.70View SEC Filing  
5/20/2013Carole S WatkinsInsiderSell4,612$48.00$221,376.00View SEC Filing  
5/20/2013Jean G SpauldingDirectorSell1,666$47.90$79,801.40View SEC Filing  
11/1/2012Stuart G LawsCAOSell2,564$41.22$105,688.08View SEC Filing  
10/4/2012Jeffrey William HendersonCFOSell46,226$40.00$1,849,040.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cardinal Health (NYSE CAH) News Headlines

Source:
DateHeadline
Cardinal Health (CAH) Upgraded at Zacks Investment ResearchCardinal Health (CAH) Upgraded at Zacks Investment Research
www.americanbankingnews.com - April 25 at 11:42 AM
Royal Bank of Canada Reiterates $81.00 Price Target for Cardinal Health (CAH)Royal Bank of Canada Reiterates $81.00 Price Target for Cardinal Health (CAH)
www.americanbankingnews.com - April 25 at 10:30 AM
Leerink Swann Weighs in on Cardinal Healths Q1 2019 Earnings (CAH)Leerink Swann Weighs in on Cardinal Health's Q1 2019 Earnings (CAH)
www.americanbankingnews.com - April 25 at 9:45 AM
Contrasting PetIQ (PETQ) and Cardinal Health (CAH)Contrasting PetIQ (PETQ) and Cardinal Health (CAH)
www.americanbankingnews.com - April 24 at 9:14 PM
Whats in Store for Cardinal Health (CAH) in Q3 Earnings?What's in Store for Cardinal Health (CAH) in Q3 Earnings?
finance.yahoo.com - April 24 at 5:40 PM
What's in Store for Cardinal Health (CAH) in Q3 Earnings?What's in Store for Cardinal Health (CAH) in Q3 Earnings?
finance.yahoo.com - April 24 at 5:40 PM
Cardinal Health (CAH) Upgraded to Outperform by Leerink SwannCardinal Health (CAH) Upgraded to Outperform by Leerink Swann
www.americanbankingnews.com - April 24 at 8:55 AM
Cardinal Health (CAH) Set to Announce Quarterly Earnings on MondayCardinal Health (CAH) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - April 23 at 5:02 AM
Cardinal Health (CAH) Receives Consensus Rating of "Hold" from AnalystsCardinal Health (CAH) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - April 22 at 7:42 PM
Cardinal Healths (CAH) "Outperform" Rating Reaffirmed at Evercore ISICardinal Health's (CAH) "Outperform" Rating Reaffirmed at Evercore ISI
www.americanbankingnews.com - April 19 at 11:20 PM
McKesson - Deeply UndervaluedMcKesson - Deeply Undervalued
seekingalpha.com - April 19 at 5:47 PM
Cardinal Health (CAH) Stock Rating Lowered by BidaskClubCardinal Health (CAH) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 19 at 1:56 PM
Cardinal Health (CAH) Downgraded by Zacks Investment Research to HoldCardinal Health (CAH) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 17 at 12:47 PM
Cardinal Health (CAH) Downgraded by BidaskClub to HoldCardinal Health (CAH) Downgraded by BidaskClub to Hold
www.americanbankingnews.com - April 16 at 8:40 PM
Cardinal Health (CAH) Price Target Cut to $68.00 by Analysts at BarclaysCardinal Health (CAH) Price Target Cut to $68.00 by Analysts at Barclays
www.americanbankingnews.com - April 16 at 2:24 PM
Cardinal Health (CAH) Upgraded by Zacks Investment Research to BuyCardinal Health (CAH) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - April 16 at 12:05 PM
$33.58 Billion in Sales Expected for Cardinal Health (CAH) This Quarter$33.58 Billion in Sales Expected for Cardinal Health (CAH) This Quarter
www.americanbankingnews.com - April 16 at 4:00 AM
Zacks: Analysts Expect Cardinal Health (CAH) Will Announce Earnings of $1.51 Per ShareZacks: Analysts Expect Cardinal Health (CAH) Will Announce Earnings of $1.51 Per Share
www.americanbankingnews.com - April 14 at 9:17 AM
Credit Suisse Group Lowers Cardinal Health (CAH) Price Target to $81.00Credit Suisse Group Lowers Cardinal Health (CAH) Price Target to $81.00
www.americanbankingnews.com - April 13 at 5:29 PM
Top Picks For Healthcare Dividend RockstarsTop Picks For Healthcare Dividend Rockstars
finance.yahoo.com - April 13 at 8:13 AM
Cardinal Health (CAH) Earns Neutral Rating from UBSCardinal Health (CAH) Earns Neutral Rating from UBS
www.americanbankingnews.com - April 12 at 3:58 PM
Cardinal Health (CAH) Upgraded to Buy by CowenCardinal Health (CAH) Upgraded to Buy by Cowen
www.americanbankingnews.com - April 7 at 4:29 PM
Comparing Herbal Center (HLF) & Cardinal Health (CAH)Comparing Herbal Center (HLF) & Cardinal Health (CAH)
www.americanbankingnews.com - April 6 at 11:27 PM
Cardinal Health Begins Donation of Over 80,000 Doses of Life-Saving Narcan® for Distribution to Law Enforcement and First Responders in AppalachiaCardinal Health Begins Donation of Over 80,000 Doses of Life-Saving Narcan® for Distribution to Law Enforcement and First Responders in Appalachia
finance.yahoo.com - April 4 at 4:20 PM
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year ...Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year ...
www.prnewswire.com - April 4 at 8:13 AM
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2018 on May 3Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2018 on May 3
finance.yahoo.com - April 3 at 5:40 PM
Argus Cites Cardinal Healths Margin Improvements In UpgradeArgus Cites Cardinal Health's Margin Improvements In Upgrade
finance.yahoo.com - April 2 at 5:32 PM
Argus Upgrades Cardinal Health (CAH) to BuyArgus Upgrades Cardinal Health (CAH) to Buy
www.americanbankingnews.com - April 2 at 9:04 AM
Cardinal Health (CAH) PT Lowered to $67.00Cardinal Health (CAH) PT Lowered to $67.00
www.americanbankingnews.com - April 1 at 2:38 PM
Zacks Investment Research Upgrades Cardinal Health (CAH) to "Hold"Zacks Investment Research Upgrades Cardinal Health (CAH) to "Hold"
www.americanbankingnews.com - April 1 at 8:50 AM
Cardinal Health (CAH) Stock Rating Lowered by ValuEngineCardinal Health (CAH) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - March 31 at 3:20 PM
MacroGenics (MGNX) & Cardinal Health (CAH) Head-To-Head AnalysisMacroGenics (MGNX) & Cardinal Health (CAH) Head-To-Head Analysis
www.americanbankingnews.com - March 30 at 9:20 PM
Zacks: Analysts Expect Cardinal Health Inc (CAH) Will Post Quarterly Sales of $33.51 BillionZacks: Analysts Expect Cardinal Health Inc (CAH) Will Post Quarterly Sales of $33.51 Billion
www.americanbankingnews.com - March 30 at 3:04 AM
Cardinal Health Inc (CAH) Given Consensus Recommendation of "Hold" by BrokeragesCardinal Health Inc (CAH) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - March 28 at 7:32 PM
Survey Finds 40 Percent of Health Care Providers Have Canceled Surgical Cases Due to Lack of SuppliesSurvey Finds 40 Percent of Health Care Providers Have Canceled Surgical Cases Due to Lack of Supplies
finance.yahoo.com - March 28 at 5:24 PM
Cardinal Health (CAH) Coverage Initiated at Bank of AmericaCardinal Health (CAH) Coverage Initiated at Bank of America
www.americanbankingnews.com - March 24 at 9:28 PM
Is Cardinal Health (CAH) a Great Stock for Value Investors Right Now? - NasdaqIs Cardinal Health (CAH) a Great Stock for Value Investors Right Now? - Nasdaq
www.nasdaq.com - March 23 at 8:13 AM
Is Cardinal Health (CAH) a Great Stock for Value Investors Right Now?Is Cardinal Health (CAH) a Great Stock for Value Investors Right Now?
finance.yahoo.com - March 22 at 5:43 PM
Tuesday Sector Laggards: Utilities, Healthcare - Nasdaq.com - NasdaqTuesday Sector Laggards: Utilities, Healthcare - Nasdaq.com - Nasdaq
www.nasdaq.com - March 21 at 8:39 AM
Cardinal Health Highlights Commitment To Gender Equity As Part Of Womens History Month CelebrationsCardinal Health Highlights Commitment To Gender Equity As Part Of Women's History Month Celebrations
finance.yahoo.com - March 20 at 5:23 PM
Cardinal Health: Keen Valuation And Dividend Growth - Seeking AlphaCardinal Health: Keen Valuation And Dividend Growth - Seeking Alpha
seekingalpha.com - March 19 at 8:14 AM
Cardinal Health (CAH) & Bio-Rad Laboratories (BIO) Critical AnalysisCardinal Health (CAH) & Bio-Rad Laboratories (BIO) Critical Analysis
www.americanbankingnews.com - March 18 at 11:28 PM
Will These Management Changes Drive Dentsply Sirona toward a New Growth Trajectory?Will These Management Changes Drive Dentsply Sirona toward a New Growth Trajectory?
finance.yahoo.com - March 16 at 6:35 PM
Cardinal Health (CAH) Lifted to "B-" at TheStreetCardinal Health (CAH) Lifted to "B-" at TheStreet
www.americanbankingnews.com - March 15 at 1:00 PM
Cardinal Health Recognizes Nearly a Decade of Helping Healthcare ... - PR Newswire (press release)Cardinal Health Recognizes Nearly a Decade of Helping Healthcare ... - PR Newswire (press release)
www.prnewswire.com - March 14 at 8:22 AM
Cardinal Health Recognizes Nearly a Decade of Helping Healthcare Organizations Improve Patient SafetyCardinal Health Recognizes Nearly a Decade of Helping Healthcare Organizations Improve Patient Safety
finance.yahoo.com - March 13 at 7:24 PM
Zacks: Brokerages Expect Cardinal Health Inc (CAH) Will Announce Quarterly Sales of $33.51 BillionZacks: Brokerages Expect Cardinal Health Inc (CAH) Will Announce Quarterly Sales of $33.51 Billion
www.americanbankingnews.com - March 13 at 8:54 AM
Free Post Earnings Research Report: Cardinal’s Revenue Gained 6%; Adjusted EPS Jumped 13%Free Post Earnings Research Report: Cardinal’s Revenue Gained 6%; Adjusted EPS Jumped 13%
finance.yahoo.com - March 12 at 6:45 PM
Cardinal Health (CAH) Up 7.5% Since Earnings Report: Can It Continue?Cardinal Health (CAH) Up 7.5% Since Earnings Report: Can It Continue?
finance.yahoo.com - March 12 at 8:27 AM
Cardinal Health Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Corporation - PR Newswire (press release)Cardinal Health Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Corporation - PR Newswire (press release)
www.prnewswire.com - March 9 at 8:12 AM

SEC Filings

Cardinal Health (NYSE:CAH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cardinal Health (NYSE:CAH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cardinal Health (NYSE CAH) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.